Clinical trial of sustained release methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in adult criminal offenders with amphetamine addictio

Not Applicable

Completed

• Conditions: Attention Deficit Hyperactivity Disorder (ADHD); Mental and Behavioural Disorders; Disturbance of activity and attention

• Registration Number: ISRCTN77940178
• Lead Sponsor: Addiction Centre Stockholm (Beroendecentrum Stockholm) (Sweden)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10-26
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 54

Inclusion Criteria

1. Male prison inmates
2. 18 to 65 years of age
3. Those who meet the Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria for amphetamine addiction and for ADHD
4. Those who, after release from prison, have an address and phone number in Stockholm area where they can be reached

Exclusion Criteria

1. Opioid, alcohol, cannabis or benzodiazepine addiction
2. Other serious psychiatric conditions apart from substance abuse/addiction (i.e. dementia, severe depression with suicidal ideation, acute psychotic symptoms, chronic schizophrenic syndrome)
3. Ongoing medication with benzodiazepines or neuroleptics
4. Acute symptoms of withdrawal regardless of substance
5. Known heart condition
6. History of stroke
7. Other severe medical condition (cancer, hypertension, glaucoma, advanced arteriosclerosis, liver cirrhosis or any medical condition that could mean a risk for the patient)
8. Known hypersensitivity to methylphenidate

Study & Design

• Study Type: Interventional
• Study Design: Not specified